The result was a formulation that contained a tumor-associated carbohydrate (B-epitope), a T-helper epitope to active T-helper cells, and an adjuvant to induce danger signals.

• 获得的结果是一种含有肿瘤相关碳水化合物 (B-抗原决定位)、活化T-辅助细胞的T-辅助细胞抗原决定位，以及诱发危险讯号的佐药配方。